97
7
20
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T38624 | Fosifidancitinib | JAK | |
Fosifidancitinib is a potent inhibitor of JAK 1 and JAK 3. | |||
T3080 | Pyridone 6 | Janus-Associated Kinase Inhibitor I,JAK Inhibitor,CMP 6,JAK Inhibitor I | Tyrosine Kinases , JAK |
Pyridone 6 (JAK Inhibitor)(CMP 6) is a potent and selective inhibitor of JAK1 (IC50=15 nM, murine JAK1), JAK2 (IC50=1 nM), JAK3 (Ki=5 nM), and Tyk2 (IC50=1 nM); displaying significantly weaker affinities (130 nM to 10 mM... | |||
T11710 | JAK-IN-5 | JAK | |
JAK-IN-5 is a JAK inhibitor. | |||
T6217 | LFM-A13 | PLK , JAK , BTK | |
LFM-A13(IC50=2.5 μM), a specific Bruton's tyrosine kinase (BTK), is more than 100-fold specificity than other protein kinases, such as JAK1, JAK2, HCK, EGFR, and IRK. | |||
T3069 | AZD-1480 | JAK | |
AZD1480 is a novel ATP-competitive JAK2 inhibitor (IC50: 0.26 nM), selectivity act against Tyk2 and JAK3, and to a smaller extent against JAK1. AZD1480 has been used in trials studying the treatment of Solid Malignancies... | |||
T6790 | BMS-911543 | BMS911543 | Tyrosine Kinases , Histone Methyltransferase , JAK |
BMS-911543 is a potent and selective inhibitor of JAK2 with IC50 of 1.1 nM, ~350-, 75- and 65-fold selective to JAK1, JAK3 and TYK2, respectively. Phase 1/2. | |||
T4210 | SAR-20347 | SAR20347 | Tyrosine Kinases , JAK |
SAR-20347 is an inhibitor of TYK2, JAK1/2/3 (IC50: 0.6/23/26/41 nM). | |||
T5091 | FM-381 | FM381 | JAK |
FM381 is a potent covalent reversible inhibitor of JAK3. FM-381 has an IC50 of 127 pM for JAK3, with 410, 2700 and 3600-fold selectivity over JAK1, JAK2 and TYK2, respectively. | |||
T5492 | JAK3-IN-6 | JAK | |
JAK3-IN-6 is irreversible Janus Associated Kinase 3 (JAK3) inhibitor, with an IC50 of 0.15 nM | |||
T2156 | WP1066 | Apoptosis , JAK , STAT | |
WP1066 is a inhibitor of JAK2 (IC50: 2.30 μM) and STAT3 (IC50: 2.43 μM) in HEL cells; shows activity to JAK2, STAT3/5, and ERK1/2, not JAK1 and JAK3. WP1066 has been used in trials studying the treatment of Melanoma, Bra... | |||
T6122 | CEP-33779 | CEP33779 | JAK |
CEP-33779 is a novel and selective inhibitor of JAK2 with an IC50 of 1.8±0.6 nM. | |||
T14331 | Gusacitinib | ASN-002 | JAK , Syk |
Gusacitinib (ASN-002) (ASN-002) is spleen tyrosine kinase (SYK) and janus kinase (JAK) inhibitor (IC50: 5-46 nM). | |||
T8546 | BD750 | JAK , STAT | |
BD750 is an effective immunosuppressant and a JAK3/STAT5 inhibitor, inhibits IL-2-induced JAK3/STAT5-dependent T cell proliferation(IC50 of 1.5 μM and 1.1 μM in mouse and human T cells, respectively) | |||
T39113L | Povorcitinib phosphate | JAK | |
Povorcitinib phosphate is a selective JAK1 inhibitor and can be used in studies about the treatment of cutaneous lupus erythematosus and Lichen planus. | |||
T6838 | FLLL32 | Apoptosis , JAK , STAT | |
FLLL32 is an effective JAK2/STAT3 inhibitor (IC50 of <5 μM). | |||
TQ0010 | Brepocitinib | PF-06700841 | Tyrosine Kinases , JAK |
T10431 | Golidocitinib | AZD4205 | JAK |
Golidocitinib (AZD4205) is a selective JAK1 inhibitor (IC50: 73 nM) and weakly inhibits JAK2/JAK3 (IC50: >14.7, >30 μM). | |||
T1929 | Filgotinib | GLPG0634 | Tyrosine Kinases , JAK |
Filgotinib (GLPG0634) is a selective JAK1 inhibitor. The IC50 values against JAK1, JAK2, JAK3, and TYK2 are 10 nM, 28 nM, 810 nM, and 116 nM, respectively. | |||
T5382 | Ritlecitinib | PF-06651600 | JAK |
Ritlecitinib (PF-06651600) is a potent JAK3-selective inhibitor (IC50: 33.1 nM). | |||
TQ0037 | Abrocitinib | PF-04965842 | JAK |
Abrocitinib (PF-04965842) (PF-04965842) is a potent, specific and orally-active JAK1 inhibitor (IC50s: 29/803 nM for JAK1/2). | |||
T6309 | AZ960 | AZ 960 | Apoptosis , Virus Protease , JAK , Parasite |
AZ960 is an effective ATP competitive JAK2 inhibitor (IC50/Ki: <3 nM and0.45 nM). | |||
T6020 | Pacritinib | SB1518 | FLT , Tyrosine Kinases , JAK |
Pacritinib (SB1518) (SB1518) is an effective and specific inhibitor of JAK2 and FLT3 (IC50: 23/22 nM, in cell-free assays). | |||
T17019 | TCS 21311 | NIBR3049 | GSK-3 , JAK , PKC |
TCS 21311 (NIBR3049) is an effective and highly selective inhibitor of JAK3 (IC50: 8 nM). TCS 21311 inhibits PKCα, PKCθ, and GSK3β (IC50s: 13, 68, and 3 nM, respectively). It displays >100-fold selectivity over JAK1, JAK... | |||
T2378 | RGB-286638 free base | GSK-3 , MEK , JAK , CDK | |
RGB-286638 free base is a novel CDK inhibitor with IC50s of 1 nM/2 nM/3 nM/4 nM/5 nM for cyclin T1-CDK9/cyclin B1-CDK1/cyclin E-CDK2/cyclin D1-CDK4/cyclin E-CDK3/p35-CDK5 respectively; less potent against cyclin H-CDK7 a... | |||
T3065 | TG101209 | Apoptosis , FLT , c-RET , JAK , Autophagy | |
TG101209 is a selective JAK2 inhibitor with IC50 of 6 nM. | |||
T22416 | RO495 | CS-2667 | Tyrosine Kinases , JAK |
RO495 (CS-2667), a potent inhibitor of TYK2, inhibits TYK2 with IC50 of 1.5nM as tested in cell-based pharmacological assays | |||
T3072 | XL019 | Apoptosis , FLT , JAK , PDGFR | |
XL019 is a potent and selective JAK2 inhibitor with IC50 of 2.2 nM, 100 fold selectivity over JAK1. | |||
T3068 | AT9283 | J-504568 | Apoptosis , FLT , JAK , Bcr-Abl , Aurora Kinase , Autophagy |
AT9283 (J-504568) is an effective multi-targeted inhibitor of JAK2(IC50=1.2 nM) and JAK3(IC50=1.1 nM), Aurora A, Aurora B and Abl(T315I). | |||
T7503 | Upadacitinib | ABT-494 | JAK |
Upadacitinib (ABT-494) (ABT-494) is a selective Janus kinase (JAK) 1 inhibitor, which is being studied for the treatment of several autoimmune disorders in the IC50 of 43 nM. | |||
T12266 | Ilginatinib | NS-018 | Tyrosine Kinases , JAK |
Ilginatinib (NS-018) is a highly active and orally bioavailable inhibitor of JAK2. | |||
T6321 | Tofacitinib | Tasocitinib,CP-690550 | ROCK , Apoptosis , JAK , Src |
Tofacitinib (Tasocitinib) is an oral, small molecule inhibitor of Janus kinases that is used to treat moderate-to-severe rheumatoid arthritis. | |||
T3042 | JAK2 Inhibitor V | JAK2 Inhibitor V Z3,Z3 | JAK |
JAK2 Inhibitor V (JAK2 Inhibitor V Z3) is a novel specific inhibitor of Jak2, inhibiting Jak2-V617F and Jak2-WT autophosphorylation in a dose-dependent manner. | |||
T2487 | Cerdulatinib | PRT2070,PRT062070 | Tyrosine Kinases , JAK , Syk |
Cerdulatinib (PRT2070) is an novel oral dual Syk/JAK inhibitor. | |||
T12427 | Brepocitinib P-Tosylate | PF-06700841 P-Tosylate | JAK |
Brepocitinib P-Tosylate (PF-06700841 P-Tosylate) is a potent dual inhibitor of Janus kinase 1 (JAK1) and TYK2 (IC50s of 17 nM and 23 nM, respectively). | |||
T15096 | Delgocitinib | JTE-052,Corectim(Delgocitinib) | Tyrosine Kinases , JAK |
Delgocitinib (JTE-052) is a specific JAK (Janus kinase) inhibitor with IC50 values of 2.8, 2.6, 13, and 58 nM for JAK1, JAK2, JAK3, and Tyk2 respectively. Delgocitinib is involved in various inflammatory and autoimmune d... | |||
T3998 | Itacitinib | INCB39110,INCB039110 | JAK |
Itacitinib (INCB039110) is an orally bioavailable inhibitor of Janus-associated kinase 1 (JAK1) with potential antineoplastic activity. | |||
T14687 | Deucravacitinib | BMS-986165 | Tyrosine Kinases , JAK , IFNAR , Interleukin |
Deucravacitinib (BMS-986165) inhibits IL-12/23 and type I IFN pathways[1][2]. BMS-986165 is a highly selective, orally bioavailable allosteric TYK2 inhibitor for the treatment of autoimmune diseases. Which selectively bi... | |||
T3076 | GLPG0634 analog | GLPG0634 analogue | Tyrosine Kinases , JAK |
GLPG0634 analog (GLPG0634 analogue) is a specific JAK1 inhibitor with IC50 of 10/28/810/116 nM for JAK1/2/3 and TYK2, respectively. | |||
T2638 | Gandotinib | LY2784544 | VEGFR , FGFR , FLT , JAK |
LY2784544(Gandotinib (LY2784544)) is a potent JAK2 inhibitor (IC50: 3 nM), effective in JAK2V617F(Ki: 0.245 nM). The selectivity is higher 8- and 20-fold than JAK1 and JAK3. | |||
T2636 | Decernotinib | VX-509,VRT-831509 | Tyrosine Kinases , JAK |
Decernotinib (VRT-831509)(VX-509; VRT-831509) is a potent and selective Janus kinase 3 (JAK3) inhibitor with Ki of 2.5 nM; IC50 is 50-170 nM in cellular assays. | |||
T7123 | AMG-47a | VEGFR , p38 MAPK , JAK , Src | |
AMG-47a is a potent inhibitor of Lck and T cell proliferation. AMG-47a could promote the degradation of the KRAS oncoprotein. AMG-47a selectively reduced the levels of EGFP-KRASG12V protein but did not affect EGFP protei... | |||
T2485 | Baricitinib | INCB028050,LY3009104 | Tyrosine Kinases , JAK , Chk |
Baricitinib (INCB028050) is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory, immunomodulating and antineoplastic activities. | |||
T12266L2 | Ilginatinib hydrochloride | NS-018 hydrochloride | Tyrosine Kinases , JAK |
Ilginatinib hydrochloride (NS-018 hydrochloride) is a highly active and orally bioavailable inhibitor of JAK2. | |||
T12266L | Ilginatinib maleate | NS-018 maleate | Tyrosine Kinases , JAK |
Ilginatinib maleate (NS-018 maleate) is a highly active and orally bioavailable inhibitor of JAK2. | |||
T3620 | Solcitinib | GLPG-0778,GSK-2586184 | JAK |
Solcitinib (GLPG-0778) (GSK2586184, GLPG0778) is a JAK1 inhibitor. Solcitinib may be potentially used for the treatment of psoriasis, ulcerative colitis, and systemic lupus erythematosus. | |||
T1849 | Momelotinib | CYT11387,CYT387,LM-1149 | Apoptosis , JAK , Autophagy |
Momelotinib (LM-1149) is an orally bioavailable small-molecule inhibitor of Janus kinases 1 and 2 (JAK1/2) with IC50 of 11 nM/18 nM. JAK1/2 inhibitor CYT387 competes with JAK1/2 for ATP binding, which may result in inhib... | |||
T8742 | G5-7 | JAK2 inhibitor G5-7 | Apoptosis , JAK |
JAK2 inhibitor G5-7 (JAK2 inhibitor G5-7) is an orally active JAK2 inhibitor, selectively inhibits JAK2–mediated phosphorylation and activation of EGFR (Tyr1068) and STAT3 by binding to JAK2. G5-7 has the potential for g... | |||
T1829 | Ruxolitinib | INCB018424,(R)-Ruxolitinib | Apoptosis , Mitophagy , Tyrosine Kinases , JAK , Autophagy |
Ruxolitinib (INCB018424) is a JAK1/2 inhibitor (IC50=3.3/2.8 nM) that is potent and selective. Rixolitinib exhibits antitumor activity and induces autophagy and apoptosis. | |||
T22338 | 2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide | GDC046 | Others , JAK |
2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide (GDC046), a potent lead analog, has good kinase selectivity, physicochemical properties and pharmacokinetic profile. | |||
T8719 | SC99 | Apoptosis , JAK , STAT | |
SC99 is a selective inhibitor of JAK2-STAT3 activation. SC99 downregulates the expression of STAT3-modulated genes.SC99 inhibits platelet activation, aggregation and displays potent anti-myeloma, anti-thrombotic activiti... |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T4672 | Brevilin A | Apoptosis , Anti-infection , JAK , STAT , Autophagy | |
Brevilin A is a sesquiterpene lactone isolated from Centipeda minima, inhibits janus kinase activity and blocks STAT3 signaling in cancer cells with anti-tumor activity. Brevilin A is a selective inhibitor of JAK-STAT si... | |||
TJS1779 | Protosappanin A | PTA | NADPH-oxidase , IL Receptor , IκB/IKK , TNF , NF-κB , TLR , ROS , COX , HIV Protease , JAK , NO Synthase , STAT |
Protosappanin A (PTA) has anti-oxidative/nitrative activities on brain immune and neuroinflammation through regulation of CD14/TLR4-dependent IKK/IκB/NF-κB inflammation signal pathway; it exerts anti-neuroinflammatory ... | |||
TN2269 | Tetramethylcurcumin | Apoptosis , STAT | |
Tetramethylcurcumin is a novel curcumin analog, is an effective inhibitors of STAT3 phosphorylation, DNA binding activity, and transactivation in vitro.it also inhibits colony formation in soft agar, cell invasion, and e... | |||
T6S1966 | Curculigoside | Curculigoside A | Antioxidant , NF-κB , JAK , STAT |
1. Curculigoside (Curculigoside A) can prevent bone loss , improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disord... | |||
T5S0167 | Atractylenolide I | IL Receptor , TNF , TLR , JAK , STAT | |
1. Atractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS. 2. Atractylenolide... | |||
TQ0196 | Cucurbitacin I | NSC-521777,JSI-124,Elatericin B | JAK , STAT |
Cucurbitacin I (JSI-124), a natural compound, is a selective inhibitor of JAK2/STAT3 with anti-cancer activity. | |||
T4S1499 | Ginsenoside Rk1 | Apoptosis , Others , NF-κB , PI3K , JAK | |
Ginsenoside Rk1 is a component created by processing the ginseng plant at high temperatures. Ginsenoside Rk1 has an anti-inflammatory effect, suppresses the activation of Jak2/Stat3 signaling pathway and NF-κB. It also h... |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPY-04799 | IFNAR2 Protein, Human, Recombinant (His), Biotinylated | Human | HEK293 |
Interferon-alpha/beta receptor beta chain (IFNAR2) is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulate Janus protei... | |||
TMPY-05636 | G-CSF Protein, Mouse, Recombinant | Mouse | HEK293 |
Granulocyte-colony stimulating factor (G-CSF) is a growth factor and an essential cytokine belonging to the CSF family of hormone-like glycoproteins. It is produced by numerous cell types including immune and endothelial... | |||
TMPY-04829 | G-CSF Protein, Human, Recombinant | Human | HEK293 |
Granulocyte-colony stimulating factor (G-CSF) is a growth factor and an essential cytokine belonging to the CSF family of hormone-like glycoproteins. It is produced by numerous cell types including immune and endothelial... | |||
TMPK-01071 | IL-22RA1 Protein, Mouse, Recombinant (hFc) | Mouse | HEK293 |
Interleukin (IL)-22 is a member of the IL-10 family of cytokines and represents an important effector molecule of activated Th22, Th1, and Th17 cells, as well as Tc-cell subsets, gammadelta T cells, natural killer (NK), ... | |||
TMPK-01105 | IL-22RA1 Protein, Human, Recombinant (hFc) | Human | HEK293 |
Interleukin (IL)-22 is a member of the IL-10 family of cytokines and represents an important effector molecule of activated Th22, Th1, and Th17 cells, as well as Tc-cell subsets, gammadelta T cells, natural killer (NK), ... | |||
TMPJ-00356 | GHR/Growth Hormone R Protein, Mouse, Recombinant (hFc) | Mouse | Human Cells |
Growth hormone receptor is a transmembrane receptor for growth hormone (GH). GH is a single-chain polypeptide that is mainly synthesized and released from the anterior pituitary gland and plays essential roles in growth,... | |||
TMPY-05465 | IL-20RB Protein, Mouse, Recombinant (His) | Mouse | HEK293 |
IL20RB belongs to the type II cytokine receptor family. There are two kinds of type II cytokine receptors: cytokine receptors that bind type I and type II interferons; cytokine receptors that bind members of the interleu... | |||
TMPY-04711 | IL-20RB Protein, Cynomolgus, Recombinant (hFc) | Cynomolgus | HEK293 |
IL20RB belongs to the type II cytokine receptor family. There are two kinds of type II cytokine receptors: cytokine receptors that bind type I and type II interferons; cytokine receptors that bind members of the interleu... | |||
TMPY-03086 | IL-20RB Protein, Rat, Recombinant (hFc) | Rat | HEK293 |
IL20RB belongs to the type II cytokine receptor family. There are two kinds of type II cytokine receptors: cytokine receptors that bind type I and type II interferons; cytokine receptors that bind members of the interleu... | |||
TMPY-04712 | IL-20RB Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 |
IL20RB belongs to the type II cytokine receptor family. There are two kinds of type II cytokine receptors: cytokine receptors that bind type I and type II interferons; cytokine receptors that bind members of the interleu... | |||
TMPY-02902 | IL-20RB Protein, Rat, Recombinant (His) | Rat | HEK293 |
IL20RB belongs to the type II cytokine receptor family. There are two kinds of type II cytokine receptors: cytokine receptors that bind type I and type II interferons; cytokine receptors that bind members of the interleu... | |||
TMPY-05559 | IL-20RB Protein, Human, Recombinant (His) | Human | Baculovirus-Insect Cells |
IL20RB belongs to the type II cytokine receptor family. There are two kinds of type II cytokine receptors: cytokine receptors that bind type I and type II interferons; cytokine receptors that bind members of the interleu... | |||
TMPJ-00398 | IL-12RB2 Protein, Mouse, Recombinant (hFc) | Mouse | Human Cells |
The IL12 receptor complex, formed by IL12RB1 and IL12RB2, mediates the type I immune responses of various types of lymphocytes. Its ligand, IL12, is a heterodimeric cytokine composed of IL-12p35 and IL-12p40 subunits tha... | |||
TMPJ-00194 | IL-20RB Protein, Human, Recombinant (hFc) | Human | Human Cells |
Interleukin-20 receptor subunit beta(IL20RB) is a single-pass type I membrane protein and belongs to the type II cytokine receptor family. It contains 2 fibronectin type-III domains. There are two kinds of type II cytoki... | |||
TMPY-02467 | ISG15 Protein, Human, Recombinant (mature form) | Human | E. coli |
Interferon-induced 17 kDa protein (ISG15), a 15-kDa protein of unique primary amino acid sequence, functions intracellularly as a ubiquitin homolog and a cytokine that induces production of IFN-gamma and augments NK / ly... | |||
TMPY-02348 | ISG15 Protein, Human, Recombinant | Human | E. coli |
Interferon-induced 17 kDa protein (ISG15), a 15-kDa protein of unique primary amino acid sequence, functions intracellularly as a ubiquitin homolog and a cytokine that induces production of IFN-gamma and augments NK / ly... | |||
TMPY-01640 | IFNAR2 Protein, Human, Recombinant (hFc) | Human | HEK293 |
Interferon-alpha/beta receptor beta chain (IFNAR2) is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulate Janus protei... | |||
TMPY-00139 | IFNAR2 Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 |
Interferon-alpha/beta receptor beta chain (IFNAR2) is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulate Janus protei... | |||
TMPY-01642 | IFNAR2 Protein, Human, Recombinant (His) | Human | HEK293 |
Interferon-alpha/beta receptor beta chain (IFNAR2) is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulate Janus protei... | |||
TMPY-00813 | G-CSF Protein, Human, Recombinant (hFc) | Human | HEK293 |
Granulocyte-colony stimulating factor (G-CSF) is a growth factor and an essential cytokine belonging to the CSF family of hormone-like glycoproteins. It is produced by numerous cell types including immune and endothelial... |